Author:
Bodega G.,Su�rez I.,Boyano M. C.,Rubio M.,Villalba R. M.,Arilla E.,Gonz�lez-Guijarro L.,Fern�ndez B.
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine,Biochemistry
Reference34 articles.
1. Cooper, A. J. L., and Plum, F. 1987. Biochemistry and physiology of brain ammonia. Physiol. Rev. 67:440?519.
2. Schenker, S. 1989. Hepatic encephalopathy: the present and future. Pages, 3?24,in Butterworth, R. F., and Pomier, G. (eds.), Hepatic encephalopathy. Pathophysiology and treatment, Humana, Clifton, NJ.
3. Basile, A. S., Jones, E. A., and Skolnick, P. 1991. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Pharmacol. Rev. 43:27?71.
4. Butterworth, R. F., Giguère, J. F., Michaud, J., Lavoie, J., and Pomier, G. 1987. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem. Pathol. 6:1?12.
5. Jessy, J., Mans, A. M., DeJoseph, M. R., and Hawkins, R. A. 1990. Hyperammonaemia causes many of the changes found after portacaval shunting. Biochem. J. 272:311?317.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献